Female Sexual Disorders
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
October 13, 2026FDA, Female Sexual Disorders, Genito-Urinary system, HRT, Obstetrics & Gynaecology, specialty pharmaceuticals, women's health
Netherlands-based clinical-stage biopharmaceutical company developing innovative therapies for women with Female Sexual Disorders (FSD), Arletta Pharma Solutions has appointed Jeannette …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
